Epitopes of strain A22 Iraq 24/64 of foot-and-mouth disease virus have been mapped with monoclonal antibodies (MAbs). Three methods were used : (i) an indirect ELISA using an overlapping set of peptides, (ii) production of neutralization escape variants against each MAb and (iii) sequencing of neutralization escape variants. The study has shown that the virus has at least three overlapping linear neutralizing epitopes within a major antigenic site on VP1. The presence of a second, conformational site was demonstrated but its position on the virus particle was not located. Synthetic peptides with sequences representing the major site elicit antibodies which have similar broad cross-neutralizing activity to polyclonal serum or neutralizing MAbs produced with the virus against a range of field isolates.
INTRODUCTION
Antigenic variation is an important feature of foot-and-mouth disease virus (family Picornaviridae, genus aphthovirus). There are seven serotypes and considerable antigenic diversity is seen between viruses within serotypes. This antigenic variation has implications for the development and use of vaccine strains, those which elicit antibodies capable of neutralizing a broad range of field viruses being preferred to viruses with a narrow antigenic spectrum.
Following adaptation to growth in monolayer BHK-21 cells the virus strain A22 Iraq 24/64 elicits antibodies that neutralize a wide range of field strains of the A virus serotype . However, passage of this virus in BHK suspension cells leads to the selection of variants with a very narrow antigenic spectrum (Bolwell et al., 1989) . Cloned progeny from the monolayer-grown virus (162-154) or suspension-grown virus (148-173) had essentially the same antigenic properties as the parent stocks from which they were derived, showing that these properties were not due to the presence of mixtures of antigenic variants. Furthermore, monoclonal antibodies (MAbs) elicited by the cloned monolayer-adapted virus (162-154) neutralized a wide range of field strains indicating that broad spectrum antigenic properties can reside in a single epitope on the virus. The most important antigenic site on FMDVs has been shown to include sequences between amino acids 141 to 160 of VP1 (Bittle et al., 1982; Pfaff et al., 1982; Strohmaier et al., 1982) but surprisingly the 162-154 and 148-173 viruses have no sequence differences in the VP1 proteins. Only three amino acid substitutions were found, all located in VP2 (Bolwell et al., 1989) .
In this paper we have defined the epitopes recognized by the 162-154 MAbs both by sequencing neutralization-resistant mutants and by analysing the reaction of the MAbs with synthetic peptides. The results confirm the importance of the 141 to 160 region of VP1 and indicate that this sequence occurs as a linear epitope on the virus particle. 
METHODS
Viruses. Virus of serotype A22 strain lraq 24/64, isolated from cattle during an outbreak in Iraq in 1964 (Arrowsmith, 1975) , was used after two passages in primary pig kidney cell monolayers and 13 passages in BHK-21 monolayer cells (virus stock 162) and after adaptation to growth in suspension cells by a further three passages in spinner culture (virus stock 148). Viruses were cloned from these stock samples by the method described by Parry et al. (1978) . Briefly, single virus plaques from BHK monolayers grown under agar were picked and passaged in BHK monolayer cells under liquid medium. Plaque selection was repeated twice more to produce the cloned virus stocks 162-154 and 148-173. The cloned viruses were stored in 50 ~ glycerol at -20 °C as stocks for two-dimensional microneutralization tests . Five other viruses belonging to serotype A, from outbreaks occurring between 1970 and 1980, were grown in BHK monolayers.
Syntheticpeptides. Peptides were synthesized by the 'tea bag' method of Houghten (1985) using conventional tBoc chemistry. All peptides correspond to the derived sequence of VPl of An Iraq 24/64 162-154 (Bolwell et al., 1989) and each had an extra cysteine residue added at the C terminus. Peptides 21 and 111 both represented amino acids 135 to 160 but in peptide 21 the hydroxyl group of tyrosine 137 was blocked with an o-benzyl group. All side chains were completely unblocked in all the other peptides used. Peptide 94 represented amino acids 137 to 165. Peptides 1 to 15 were an overlapping series of 20 residue peptides synthesized at intervals of two amino acids and covering, in total, amino acids 121 to 168, each with an additional C-terminal cyste~ne (see Fig. 1 ). Peptide 16 contained the C-terminal sequence of VP1, residues 200 to 213.
Anti-peptide antisera. Synthetic peptide 111 was emulsified in incomplete Freund's adjuvant and injected intramuscularly into Dunkin Hartley outbred guinea-pigs using 100 ~tg peptide per animal. The animals were boosted with the same formulation at 36 and 99 days post-infection (p.i.) and blood was collected at 120 days p.i. Antisera were also raised to peptide 94 but each animal received 200 ~tg per injection formulated in a commercial water-in-oil emulsion and they were boosted once at 42 days p.i.; blood was collected at 84 days p.i.
MAbs. These were prepared as described in Bolwell et al. (1989) . Two-dimensional microneutralization assay. The method used was as described by Bolwell et al. (1989) .
Indirectpeptide ELISA. An indirect peptide assay technique was used to map the antigenic sites using a series of overlapping peptides. Microtitre plates were coated with 3 ~tg/ml of test peptide in carbonate coating buffer (Ouldridge et al., 1982) . After incubation for 1 h at 37 °C, plates were washed three times with phosphate-buffered saline/0.05~ Tween 20 solution. Test sera or MAb at 1/10 dilution were added to the top row of wells and serial twofold dilutions were made down the plate. After 1 h at 37 °C plates were again washed and 50 ~tl of a 1/5000 dilution of rabbit anti-mouse horseradish peroxidase conjugate was added to each well. After a further 1 h at 37 °C the plates were again washed and an enzyme substrate (0.4 ~ o-phenylenediamine, 0-004~ hydrogen peroxide in phosphate/citric buffer) was added. Colour development was then stopped with 12.5~ sulphuric acid and absorbance values were measured at 492 nm.
Production of MAb escape variants.
Virus variants refractory to neutralization by a specific MAb were produced using a plaque reduction technique described by Minor et al. (1983) . Briefly, BHK-21 cells were grown as confluent monolayers on 9 cm Petri dishes, washed with 0.04 M-phosphate buffer and infected with serial log10 dilutions of virus 162-154 premixed (1 h at 37 °C) with an equal volume of either the MAb under test or diluent alone (0-04 Mphosphate buffer, 1 ~ bovine serum albumin). After incubation at 37 °C for 1 h plates were overlaid with 20 ml of 0.76~o agar Noble incorporating a 1/50 dilution of the same MAb or diluent. Plates were then incubated at 37 °C for 24 h before adding a further 5 ml overlay containing a vital stain 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride to visualize plaques and then incubated a further 24 h at 37 °C. Variant viruses were removed in agar plugs from plates which contained single variant virus plaques (i.e. those which were of similar size to plaques produced in the absence of antibody). The agar plug was then placed on a preformed BHK monolayer and 10 ml of an Eagle's-based medium was added. After 24 h at 37 °C, the virus was harvested and stored in 50~ glycerol at -20 °C. Viruses were then tested in a two-dimensional neutralization assay against the selecting MAb and only viruses that were completely refractory to neutralization were classed as variant and used in further studies.
Sequencing of viral RNA. Sequencing was carried out by the primer extension/dideoxynucleotide chain termination method directly from virus RNA (Caton et al., 1982) using 2 ~tg RNA and a synthetic deoxynucleotide primer. The primer used was complementary to the P2A region of the FMDV genome (Rowlands et al., 1983) and allowed direct sequencing from the carboxy terminus of VP1 through the major immunogenic region 141 to 160.
RESULTS

Neutralizing MAbs recognize peptides representing the major determinants of VP1
Monoclonal antibodies induced with the monolayer-adapted virus (clone 162-154) were tested for recognition of synthetic peptides in an indirect ELISA system in which the peptides were immobilized by binding to ELISA plates (Bolwell et al., 1989 ). Three peptides were tested: (i) peptide 21 represented VP1 amino acids 135 to 160 with an additional cysteine residue at the C terminus (135-160Cys; the tyrosine residue at 137 was still protected with o-benzyl in this peptide), (ii) peptide 111 which had the same sequence as peptide 21 but all of the side chains were fully deprotected and (iii) peptide 94 which had the sequence of amino acids 137 to 165, again with an additional C-terminal cysteine (137-165Cys). The results obtained for each peptide with 10 different MAbs are shown in Table 1 . Two values were measured: the plateau value, which is the maximum absorbance produced in antibody excess and log10K which is the loglo dilution of antibody that produced an absorbance 50~o of that of the plateau value .
Most of the neutralizing MAbs recognized all three peptides similarly, but one (H) gave consistently lower plateau absorbance values with peptide 21 than with peptides 94 or 111. The two non-neutralizing MAbs failed to recognize the peptides and the reaction of the two IgM MAbs could not be measured because of the high background values obtained with these antibodies.
Serological spectra of antipeptide sera
Since neutralizing MAbs recognized peptides from the 135 to 160 region of VP1, antisera against 135-160Cys and 135-167Cys peptides were tested for their neutralizing activities with a range of field isolates (Table 2 ). In general the anti-peptide antisera neutralized as wide a range of serotype A viruses as the MAbs (Bolwell et al., 1989) and were virtually as cross-reactive as polyclonal serum raised with the 162-154 virus and much more cross-reactive than polyclonal serum raised with the suspension cell-adapted virus, 148-173. Antiserum to the 135-167Cys peptide was more specific than that raised to peptide 135-160Cys (see A Burma 6/78, Table 2 ). 
* Tyrosine residue at position 137 was blocked with an O-benzyl group.
i" For neutralization details see Bolwell et al. (1989) .
~:NR, No specific ELISA reaction above that of negative mouse fusion material produced from the spleen of a non-immunized mouse. antiserum and the 135-167Cys antisera failed to neutralize this virus. In common with the MAbs, none of the peptide antisera neutralized the Pakistan 7/80 strain whereas polyclonal serum against virus 162-154 neutralized this virus well (Bolwell et al., 1989) .
Mapping of MAb epitopes by cross-neutralization of selected neutralization-resistant mutants
Neutralization-resistant mutants selected with five of the IgG MAbs were tested for their susceptibility to neutralization by each of the eight neutralizing MAbs (Fig. 2) . The crossneutralization patterns fell into three groups, the first of which included six of the eight MAbs On: Tue, 26 Mar 2019 18:38:26 and was characterized by its failure to neutralize all the variants selected with MAbs B, E and F. However, variants selected with MAbs H and I were still neutralized by Group 1 MAbs. Group 2, which consisted of MAb H only, gave mixed patterns of neutralization with variants selected with MAbs B, E and F. The third group, represented by MAb I, was clearly distinct in that mutants selected with this antibody were still neutralized by all the other MAbs. Groups 1 and 2 would appear from this analysis to recognize different overlapping epitopes within a single antigenic site while the group 3 MAb recognizes an independent site.
Epitope mapping of FMDV with MAbs
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Mapping of MAb epitopes using an overlapping set of peptides
The eight IgG MAbs that had virus-neutralizing activity and polyclonal antiserum against peptide 111 were tested by indirect ELISA against the overlapping set of peptides shown in Fig.  1 . The results are presented graphically in Fig. 3 . The polyclonal anti-peptide serum reacted well with 11 of the overlapping set of peptides but gave only weak reactions with peptides 1 and 2. ;'"'" " " : +'"'"''" ' "". ;" "'+.+'".i';'' 3 "+.'."
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-"...,::. There was no reaction with either the last two N-terminal peptides (14 and 15) or the control Cterminal peptide (1 6) (Fig. 3 a) . The reaction patterns of the MAbs fell into three groups. Group la, represented by MAbs A (Fig. 3b) , F (Fig. 3c ) and E (Fig. 3d) , reacted with peptides 3 to 8. Group lb [MAb B (Fig. 3e) , C (Fig. 3f) and D (Fig. 3g) also true of anti-peptide polyclonal antisera (Fig. 3a ) the reactions were considered to be significant. Group 2 (MAb H) reacted with peptides 7, 8 and 9 only (Fig. 3h) . The final group represented by MAb I failed to recognize any of the peptides. These data suggest that the epitope recognized by group la MAbs lies between amino acids 145 and 154, that for group lb between 147 and 154 and that for group 2 between 137 and 152. The epitope recognized by MAb I could not be mapped with this series of peptides.
Mapping of MAb epitopes by sequencing of selected neutralization-resistant variants
All the neutralization escape variant viruses obtained were sequenced by the chain termination method directly from virus RNA using a primer appropriate for the 135 to 160 region of VP1. Nucleotide changes resulting in single amino acid substitutions were clearly identified in all of the mutants except for those selected with MAb I. The positions and nature of the coding changes observed in the variants are shown in Table 3 . They fall into three groups which correlate well with the groupings obtained by cross-neutralization and overlapping peptide mapping. The first group, which includes variants selected with MAbs E, F and B, have substitutions within the region 149 to 154, specifically at residues 149, 150, 153 or 154, with a predominance of changes at 150. The variant selected with MAb F clearly had a change at position 150 but the substituted amino acid could not be identified with certainty because of sequencing ambiguity. The second group comprised variants selected with H in which substitutions clustered between residues 138 and 144, specifically at positions 138, 140, 142 and 144. The final group, typified by variants selected with MAb I, had no substitution in the Cterminal half of VP1 including 135 to 160. The positions of the mutations in these viruses were not determined.
DISCUSSION
In the accompanying paper (Bolwell et aL, 1989) we have shown that adaptation of A Iraq 24/64 virus for growth in BHK suspension cells invariably selected a virus population that differed in several respects from the original BHK monolayer-grown virus. One of the differences between the monolayer and suspension cell-selected viruses was a striking change in their antigenic characteristics. The monolayer-grown virus induced antibodies which neutralized a wide range of field strains in the A22 group equally well, whereas the antibodies induced by the suspension cell-selected virus were highly strain-specific. Viruses derived from the original stocks by plaque purification displayed the same properties as their progenitors. MAbs induced with the monolayer cell-grown virus were also broadly cross-reactive in neutralization tests but, surprisingly, no amino acid-coding sequence differences were found in the VP 1-coding region of the two viruses. This result was unexpected for two reasons: first, it has been established with many strains of FMDV that the dominant neutralization epitope is (Bittle et al., 1982; Pfaff et al., 1982; Strohmaier et al., 1982; Rowlands et al., 1983; Parry et al., 1985; Xie et al., 1987) ; second, the A22 MAbs failed to recognize virus which had been treated with trypsin, which cleaves VP1 in the region of the major immunogenic site but does not apparently affect the other capsid proteins. For these reasons we attempted to map the epitopes recognized by the MAbs and to investigate the nature of antibodies elicited with synthetic peptides including the 141 to 160 sequence of the virus. The eight neutralizing MAbs of the IgG class recognized peptides 135-160Cys and 137-165Cys in indirect ELISA in which the peptides were bound directly to the solid phase. This is in striking contrast to our experience with MAbs induced with serotype O viruses, which recognize synthetic peptides only in free solution (N. R. Parry, unpublished results), and suggests that the Az2 MAbs recognize linear epitopes. One of the MAbs (H) reacted less well with a 135-160Cys peptide in which the trypsin residue at position 137 was still blocked with a side chain-protecting group. The two non-neutralizing IgG MAbs failed to recognize the peptides and results were not obtained with the IgM antibodies because of the high background readings obtained.
Since the MAbs clearly recognized sequences in the region of VP1 shown to be immunodominant in other FMDVs, the neutralizing activity of these peptide antisera was examined. Antiserum raised to peptide 141-160Cys had similar cross-neutralizing specificity against a range of A viruses as did the MAbs and was almost as broad in its activity as polyclonal serum raised to the monolayer cell-adapted virus. There was some indication that the longer peptide, 135-167Cys induced slightly more specific antisera than the 141-160Cys peptide. The broad spectrum response to these peptides is particularly interesting since, as shown in the accompanying paper (Bolwell et al., 1989) , the sequence of narrow antigenic spectrum suspension cell-adapted virus is identical to the monolayer cell virus throughout VP1.
The results obtained with three methods for mapping the epitopes recognized by the neutralizing IgG MAbs correlated very well and are summarized in Fig. 3 . Each method separated the MAbs into the same three groups. The antibodies in group 1, containing six of the eight MAbs, were related in their ability to cross-neutralize MAb-selected variants and by the location of amino acid substitutions in neutralization-resistant viruses selected with them. The group could be subdivided on the basis of reactivities with the overlapping set of peptides, group 1 a recognizing peptides containing amino acids 147 to 154 and group l b reacting with peptides containing 145 to 154. Group 2, represented by a single MAb, H, was related to, but distinct from, group 1 MAbs by cross-neutralization of MAb-resistant variants. Peptide mapping and the location of amino acid substitutions in neutralization-resistant mutants showed that the group 2 epitope overlapped that of group 1 and was extended to the N-terminal side including amino acids 137 to 152. The tyrosine residue at position 137 which was blocked in peptide 21 is therefore part of the epitope recognized by MAb H and would account for the difference in reactivity with peptide 21 and the unblocked peptide 94. The third group again consisted of a single MAb. This recognized a distinct epitope which probably resides in an antigenic site different from that containing the group 1 and group 2 epitopes since it did not recognize any of the peptides and did not select for viruses with substitutions in the C-terminal half of VP1.
The location of the most important antigenic site on A22 virus is between residues 145 and 154, which fits well with results obtained with viruses of the O serotype as determined with synthetic peptides (Parry et al., 1985) . However, the dominant epitopes on serotype O and A viruses seem to differ in two important respects. First, the majority of MAbs to type O viruses failed to recognize peptides bound directly to ELISA plates, whereas the type A MAbs clearly do. Second, neutralization-resistant variants selected with type O MAbs in our laboratory have no amino acid substitution in the 135 to 160 region of VP1 (P. V. Barnett et al., unpublished data) . However, Xie et al. (1987) have described substitutions at positions 144, 148 and 154 on VP1 of type O variants selected with their MAbs, although the substitutions at 144 and 154 allowed only partial resistance to neutralization. Our interpretation of these differences is that the major neutralization site of type O viruses is more conformationally constrained than that of type A viruses, which has the characteristics of a linear determinant. However, the problem remains of why the suspension cell-selected variants of A22 should be so different antigenically from the monolayer-grown virus since the only amino acid differences in the capsid proteins of the two viruses are located in VP2. This suggests that substitutions elsewhere in the capsid proteins can have a profound effect on the antigenic character of the 135 to 160 region. Such findings have already been noted for O type viruses (N. R. Parry, unpublished results) . However the 135 to 160 region on the suspension cell-selected variant is accessible to antibodies recognizing this site since the group 1 and 2 MAbs can neutralize the virus well (Bolwell et al., 1989) . The atomic structure of FMDV, serotype O~, has recently been solved by X-ray crystallography (Fox et al., 1987; R. Acharya et al., unpublished data) . By comparison with the model of the type O virus it is predicted that of the three amino acid differences in VP2 between the monolayer and suspension cell-adapted A22 viruses one is buried and the other two are close to the major antigenic loop of VP1 and may influence the configuration of this region.
